Monday, June 24, 2019

Interim scan during prostate cancer therapy helps guide treatment

New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging of patients with metastatic castration-resistant prostate cancer after two cycles of lutetium-177 (177Lu)-PSMA radioligand therapy has shown a significant predictive value for patient survival.

from Top Health News -- ScienceDaily http://bit.ly/2x9t52T
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

It’s not that you look—it’s when: The hidden power of eye contact

A groundbreaking study from Flinders University reveals that it's not just making eye contact that matters, but precisely when and how y...